Overview

Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma

Status:
Recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
A Phase I Clinical Study ofCT0180 cells in Patients with Advanced Hepatocellular Carcinoma
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang University
Collaborators:
CARsgen Therapeutics Co., Ltd.
Carsgen Therapeutics, Ltd.